InspireMD

A new level of stroke prevention is here. CGuard® Prime is now FDA-approved. With over 65,000 stents sold worldwide, we’re ready to elevate embolic prevention for U.S. physicians and their patients. 🔰Ready for a new layer of defense? CGuardPrime.com #FDAcleared

📣 Madrid Center of Excellence 2026 Carotid stenting. Live cases. Real-world insights. Featuring CGuard 🛡️ 🗓 Mar 23–24 | Madrid Led by Dr. Pedro Navia #CGuard #StrokePrevention

At the CARVE Conference in Snowmass this week, the InspireMD team gave physicians an up-close look at the MicroNet™ mesh of the CGuard® stent—with pores measuring only ~150–180 microns.🔍 The only mesh-covered carotid stent.🛡️ inspiremd.com #CGuard #StrokePrevention

🛡️ “It’s the next generation stent.” Dr. Patrick Muck, Chief of Vascular Surgery at TriHealth Good Samaritan Hospital: “You have to think about what you're leaving behind… a stent with MicroNet™ (~150–180 microns).” What stays behind matters. #CGuard #CarotidStenting 🧠🛡️

💡 Did you know? The CGuard® stent features a dual-layer architecture with MicroNet™ mesh covering that extends to the end of the stent—helping provide continuous plaque coverage. 🛡️ Learn more: InspireMD.com #CGuardPrime #StrokePrevention $NSPR

💡 Did you know? The CGuard® stent demonstrated the lowest 30-day and 1-year MAE rates of any pivotal CAS study.* 🛡️ 0.95% — 30-day DSMI 🛡️ 1.93% — 1-year composite endpoint† Learn more: CGuardPrime.com *Data on file. †Modified intent-to-treat Kaplan-Meier analysis.

Employee Spotlight: Ligia Martinez When the right product meets the right mission, it takes the right marketer to bring it to life.📣 Ligy brings the impact of CGuard® Prime and MicroNet™ mesh to physicians worldwide—advancing our mission to prevent stroke and save lives.🛡️

Lake Street Capital Markets will be hosting a virtual fireside chat with Patrick Muck, MD to discuss InspireMD's CGuard® Prime Carotid Stent System and the evolving landscape in carotid artery revascularization. Contact your Lake Street representative for additional details.

At #ISET2026, CGuard® Prime and MicroNet™ mesh were front and center. Some of the best moments happened under the microscope. 🔬 Fellows saw the mesh up close and the design spoke for itself. 🛡️ Old friends. New faces. Strong momentum. Miami delivered. 🏖️ #CarotidStenting

🛡️ ISET 2026 is headed to Miami Beach. 📍 Booth #408 | Feb 9–12 Carotid-focused talks. Hands-on sessions. Stop by or reach out while you’re in town. CGuardPrime.com #ISET2026 #CGuardPrime #carotidstenting #carotidstent

🎷 CGuard® Prime is headed to the Big Easy. 📍 #ISC2026 | New Orleans 🛡️ Booth #744 🧪 Simulation Zone — Wed & Thu Get hands-on with CGuard® Prime using simulators and walkthroughs. Learn more: CGuardPrime.com #StrokePrevention #CarotidStenting #InspireMD

LINC 2026 wrapped in Leipzig. 🛡️ Across sessions, next-generation carotid stents were a clear focus— with CGuard and MicroNet™ frequently highlighted in discussions around plaque control and stroke risk reduction. Grateful to the LINC community! #LINC2026 #CarotidStenting

Next week at LINC 2026 in Leipzig 🇩🇪 🛡️ Live CGuard® cases 📅 Tue, Jan 27 (live from Leipzig) 🕘 09:55 🕓 16:00 📍 Visit us at Booth #310 Experience the next generation of carotid stenting. 🔗 inspiremd.com/cguard #LINC2026 #CGuard #CarotidStenting

In carotid stent design, details matter. CGuard® Prime features a dual-layer design with MicroNet™ mesh—offering the smallest pore size of any carotid stent.* Thoughtful design. Purpose-built protection.🛡️ Learn more: CGuardPrime.com *Data on file

Deploys nicely

.@InspireMD recently announced that results from the C-GUARDIANS pivotal trial have now been published in @JACCJournals, demonstrating safety and efficacy with the MicroNet-covered CGuard Prime stent in patients with asymptomatic #carotid stenosis neuronewsinternational.com/c-guardians-pi…

InspireMD announces publication of the C-GUARDIANS pivotal trial in JACC. CGuard® Prime demonstrated the lowest 30-day and 1-year primary endpoint MAE rates of any pivotal CAS study.* 🛡️ 📄 Read more: Safety and Efficacy of a Novel Micro Net Carotid Stent System *Data on file

2025 was a defining year for InspireMD. 🛡️ Focused on one mission: helping prevent stroke and save lives—giving physicians confidence in carotid stenting, without compromise. Onward to an exciting 2026. 🎆

Three days in Paris. One clear message: the conversation around carotid care is evolving – and InspireMD is dedicated to shaping this next chapter. 🇫🇷🛡️

📣InspireMD is at PVI 2025 next week. 🗓Dec 11: CGuard® hands-on workshop (13:35–15:05). 🗓Dec 12: MicroNet™ symposium (11:18–11:33). Visit Booth #5 to meet the team + see the future of carotid stenting. See you in Paris! @ParisVascular #PVI2025 #CarotidStenting #CGuard

🦃 Grateful for the physicians, partners, patients & colleagues who share our commitment to preventing stroke. Every case & data point moves the field forward. At InspireMD, we're thankful for the chance to help protect patients. Happy Thanksgiving — here’s to fewer strokes. 🛡️